Panacea Biotec trades jubilantly on fund raising plan

24 Jul 2014 Evaluate

Panacea Biotec is currently trading at Rs. 185.50, up by 23.60 points or 14.58% from its previous closing of Rs. 161.90 on the BSE.

The scrip opened at Rs. 164.00 and has touched a high and low of Rs. 188.80 and Rs. 164.00 respectively. So far 36667 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 199.00 on 27-Jun-2014 and a 52 week low of Rs. 82.30 on 19-Aug-2013.

Last one week high and low of the scrip stood at Rs. 188.80 and Rs. 160.00 respectively. The current market cap of the company is Rs. 1062.09 crore.

The promoters holding in the company stood at 74.81% while Institutions and Non-Institutions held 1.69% and 23.50% respectively.

Panacea Biotec, one of the leading research based health management companies of India, is planning to Raise Rs 250 crore. In this regard, the company’s board will meet on August 1, 2014 to consider raising of funds by way of issue of securities or equivalent thereof in any currency.

The board will also consider and approve the provisional unaudited financial results for the quarter ended June 30, 2014.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

 

Panacea Biotec Share Price

135.10 2.60 (1.96%)
13-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5913.95
Cipla 1421.00
Zydus Lifesciences 993.40
Lupin 1684.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.